Characterization:novel genotoxic stress-regulated gene
表征:新型遗传毒性应激调节基因
基本信息
- 批准号:7229934
- 负责人:
- 金额:$ 18.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-03-01 至 2009-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmino Acid MotifsApoptosisBindingBinding SitesCREB1 geneCa(2+)-Calmodulin Dependent Protein KinaseCalcineurinCalcium-Binding ProteinsCalmodulinCellsCodeColonColon CarcinomaColonic NeoplasmsComplexDNA DamageDevelopmentDown-RegulationEventGenesGenotoxic StressGenus ColaHumanMediatingMediator of activation proteinMessenger RNAMolecularNamesNormal tissue morphologyNumbersPathway interactionsProtein OverexpressionProtein p53ProteinsRegulatory ElementRelative (related person)Research PersonnelRoleSequence AnalysisSignal PathwaySignal TransductionSpecimenStressTP53 geneTestingTissue MicroarrayTranscriptional ActivationTumor MarkersUp-Regulationenvironmental agentinsightmRNA Expressionnovelprogramspromoterprotein expressionresponsetumortumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Cells are constantly exposed to a variety of environmental agents some of which induce DNA damage i.e. genotoxic stress. Cellular responses to genotoxic stress are complex and therefore, more studies are needed to better understand the mechanisms that control such responses. Here we propose to characterize a novel gene, which we have named PIQ (p53-regulated IQ protein) that codes for an IQ motif protein. IQ motifs promote protein interactions with calmodulin (CaM). CaM is a calcium-binding protein that controls several important signaling events. Evidence presented here show that PIQ does indeed bind to CaM. Furthermore, PIQ mRNA is overexpressed in primary colon tumors when compared with matching normal tissues and that PIQ is down-regulated in response to genotoxic stress and p53 activation. PUMA is a key mediator of p53- dependent genotoxic stress-induced apoptosis and our results indicate that PIQ down-regulates PUMA promoter expression. Importantly, PUMA promoter harbors regulatory elements that are predicted to be regulated by CaM-dependent signaling pathways. We, therefore, propose that in unstressed cells, PIQ may negatively regulate PUMA expression by interfering with CaM-dependent signaling events and PIQ downregulation following genotoxic stress serves to promote PUMA upregulation partly via CaM-dependent pathways. Our overall hypothesis is that PIQ is a negative modulator of apoptosis and that higher levels of PIQ expression noted in colon cancer may alter the threshold of apoptosis and consequently contribute in part to colon tumorigenesis. Three specific aims are proposed here to further characterize PIQ in order to elucidate its role in cellular response to genotoxic stress in general and in the development and/or progression of colon cancer in particular. Specific Aim 1 is to investigate the role of PIQ during p53 and genotoxic stress-induced apoptosis. Specific Aim 2 is to investigate the mechanism by which PIQ negatively regulates PUMA promoter expression. Specific Aim 3 is to analyze PIQ expression at the mRNA and protein levels in a larger pool of primary colon tumors and their matching normal tissues and to evaluate a relationship between tumor PIQ-status and the clinicopathologic features.
描述(由申请人提供):细胞不断暴露于各种环境因素,其中一些环境因素会诱导 DNA 损伤,即基因毒性应激。细胞对基因毒性应激的反应很复杂,因此需要更多的研究来更好地了解控制这种反应的机制。在这里,我们建议表征一个新基因,我们将其命名为 PIQ(p53 调节的 IQ 蛋白),它编码 IQ 基序蛋白。 IQ 基序促进蛋白质与钙调蛋白 (CaM) 的相互作用。 CaM 是一种钙结合蛋白,控制多种重要的信号传导事件。这里提供的证据表明 PIQ 确实与 CaM 结合。此外,与匹配的正常组织相比,PIQ mRNA 在原发性结肠肿瘤中过度表达,并且 PIQ 因基因毒性应激和 p53 激活而下调。 PUMA 是 p53 依赖性基因毒性应激诱导细胞凋亡的关键介质,我们的结果表明 PIQ 下调 PUMA 启动子表达。重要的是,PUMA 启动子含有预计受 CaM 依赖性信号通路调节的调节元件。因此,我们提出,在未受应激的细胞中,PIQ 可能通过干扰 CaM 依赖性信号传导事件来负向调节 PUMA 表达,并且基因毒性应激后 PIQ 下调部分通过 CaM 依赖性途径促进 PUMA 上调。我们的总体假设是,PIQ 是细胞凋亡的负调节剂,结肠癌中较高水平的 PIQ 表达可能会改变细胞凋亡的阈值,从而在一定程度上促进结肠肿瘤的发生。这里提出了三个具体目标来进一步表征 PIQ,以阐明其在细胞对遗传毒性应激的反应中的作用,特别是在结肠癌的发生和/或进展中的作用。具体目标 1 是研究 PIQ 在 p53 和基因毒性应激诱导的细胞凋亡过程中的作用。具体目标2是研究PIQ负向调节PUMA启动子表达的机制。具体目标 3 是分析更大范围的原发性结肠肿瘤及其匹配的正常组织中 mRNA 和蛋白质水平的 PIQ 表达,并评估肿瘤 PIQ 状态与临床病理特征之间的关系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M. SAEED SHEIKH其他文献
M. SAEED SHEIKH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M. SAEED SHEIKH', 18)}}的其他基金
Development of dihydroartemisinin as a novel preventive agent for prostate cancer
双氢青蒿素作为前列腺癌新型预防剂的开发
- 批准号:
8050362 - 财政年份:2011
- 资助金额:
$ 18.45万 - 项目类别:
Development of dihydroartemisinin as a novel preventive agent for prostate cancer
双氢青蒿素作为前列腺癌新型预防剂的开发
- 批准号:
8242022 - 财政年份:2011
- 资助金额:
$ 18.45万 - 项目类别:
A novel biomarker and therapeutic target for breast cancer
乳腺癌的新型生物标志物和治疗靶点
- 批准号:
8220835 - 财政年份:2011
- 资助金额:
$ 18.45万 - 项目类别:
A novel biomarker and therapeutic target for breast cancer
乳腺癌的新型生物标志物和治疗靶点
- 批准号:
8062885 - 财政年份:2011
- 资助金额:
$ 18.45万 - 项目类别:
Characterization of a novel stress-regulated anti-apoptotic ubiquitin ligase
新型应激调节抗凋亡泛素连接酶的表征
- 批准号:
7567486 - 财政年份:2008
- 资助金额:
$ 18.45万 - 项目类别:
Characterization of a novel stress-regulated anti-apoptotic ubiquitin ligase
新型应激调节抗凋亡泛素连接酶的表征
- 批准号:
7466107 - 财政年份:2008
- 资助金额:
$ 18.45万 - 项目类别:
PDRG, a novel p53 and DNA damage-regulated gene and colorectal cancer
PDRG,一种新型 p53 和 DNA 损伤调节基因与结直肠癌
- 批准号:
7265025 - 财政年份:2007
- 资助金额:
$ 18.45万 - 项目类别:
PDRG, a novel p53 and DNA damage-regulated gene and colorectal cancer
PDRG,一种新型 p53 和 DNA 损伤调节基因与结直肠癌
- 批准号:
7426429 - 财政年份:2007
- 资助金额:
$ 18.45万 - 项目类别:
Characterization:novel genotoxic stress-regulated gene
表征:新型遗传毒性应激调节基因
- 批准号:
7030099 - 财政年份:2006
- 资助金额:
$ 18.45万 - 项目类别:
COX-2 and p53 interactions and cancer prevention
COX-2 和 p53 相互作用与癌症预防
- 批准号:
6804993 - 财政年份:2003
- 资助金额:
$ 18.45万 - 项目类别:
相似国自然基金
三疣梭子蟹两种含不同关键氨基酸基序C型凝集素的糖识别机制研究
- 批准号:31702375
- 批准年份:2017
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
CRAC中心酪氨酸突变介导肝细胞胆小管侧膜BSEP膜胆固醇敏感性及转运功能减退的分子机制
- 批准号:81670580
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
相似海外基金
Defining the role of RBM10 in RNA processing and tumor suppression
定义 RBM10 在 RNA 加工和肿瘤抑制中的作用
- 批准号:
8983196 - 财政年份:2015
- 资助金额:
$ 18.45万 - 项目类别:
Epigenetics of human Hepatic Stellate Cells (HSCs) in NASH
NASH 中人肝星状细胞 (HSC) 的表观遗传学
- 批准号:
10680588 - 财政年份:2014
- 资助金额:
$ 18.45万 - 项目类别:
Epigenetics of human Hepatic Stellate Cells (HSCs) in NASH
NASH 中人肝星状细胞 (HSC) 的表观遗传学
- 批准号:
10367096 - 财政年份:2014
- 资助金额:
$ 18.45万 - 项目类别:
Dynamics of transmembrane dimers in TNF-Receptors by EPR and molecular simulation
通过 EPR 和分子模拟研究 TNF 受体跨膜二聚体的动态
- 批准号:
8827818 - 财政年份:2014
- 资助金额:
$ 18.45万 - 项目类别:
Dynamics of transmembrane dimers in TNF-Receptors by EPR and molecular simulation
通过 EPR 和分子模拟研究 TNF 受体跨膜二聚体的动态
- 批准号:
9250185 - 财政年份:2014
- 资助金额:
$ 18.45万 - 项目类别: